NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

NCT03387423

CompletedN/A

Sponsor: Pfizer

Conditions: Arthritis, Rheumatoid

Interventions: Tofacitinib

Countries: Germany

This non-interventional study aims to identify key factors that are driving treatment decisions by rheumatologists in the treatment of rheumatoid arthritis (RA) patients starting treatment with Tofacitinib in a real world setting.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Patients aged ≥ 18 years

Confirmed Diagnosis of Rheumatoid Arthritis by rheumatologist

Patient is eligible for Tofacitinib treatment according to Summary of Product Characteristics (SmPC)

Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.

Exclusion Criteria:

Contraindications according to Xeljanz® SmPC

Receipt of any investigational drug within 3 months before study inclusion

Patients who have received any previous treatment with Tofacitinib or other JAK inhibitors

Patients who are investigational site staff members or patients who are Pfizer employees directly involved in the conduct of the study.

Locations (91)

Düsseldorf, North Rhine-Westphalia, Germany
Zschopau, Saxony, Germany
Altenburg, Germany
Altenholz, Germany
Amberg, Germany
Augsburg, Germany
Bad Bramstedt, Germany
Bad Kreuznach, Germany
Bad Pyrmont, Germany
Bamberg, Germany
Bayreuth, Germany
Bayreuth, Germany
Bayreuth, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Bernau, Germany
Braunschweig, Germany
Burghausen, Germany
Chemnitz, Germany
Cologne, Germany
Deggendorf, Germany
Demmin, Germany
Dortmund, Germany
Dresden, Germany
+ 61 more on CT.gov